# Study to Determine the Effect of an Anti-IgE Agent on Inflammatory Cells in the Skin of Atopic Dermatitis Patients

> **NCT00822783** · PHASE4 · COMPLETED · sponsor: **Medical University of Vienna**

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Omalizumab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00822783
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-10
- **Primary completion:** —
- **Final completion:** 2003-04
- **Target enrollment:** — (—)
- **Last updated:** 2009-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00822783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00822783, "Study to Determine the Effect of an Anti-IgE Agent on Inflammatory Cells in the Skin of Atopic Dermatitis Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00822783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*